ARTA
SPHS

A.R.T. Advisors’s Sophiris Bio, Inc. SPHS Stock Holding History

A.R.T. Advisors’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-14,704
Closed -$12K – 1926
2019
Q2 		$12K Buy
+14,704
New +$12.9K ﹤0.01% 1307
2018
Q4 		– Sell
-44,143
Closed -$123K – 1893
2018
Q3 		$123K Buy
+44,143
New +$126K 0.01% 1257
2016
Q4 		– Sell
-13,200
Closed -$41K – 1484
2016
Q3 		$41K Buy
+13,200
New +$49.7K 0.01% 598

Other funds holding SPHS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BO
BRR OpCo Columbus, Ohio $814M AUM 9.75% 1-Year Est. Return
ACM
Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

A.R.T. Advisors's SPHS Position: Q3 2019 in Review

A.R.T. Advisors sold out of Sophiris Bio, Inc. (SPHS) in Q3 2019, closing a stake of 14,704 shares — an estimated $12K sold.

A.R.T. Advisors first reported a position in SPHS in Q3 2016 and held it in 3 quarters. The position peaked at $123K in Q3 2018. 25 funds tracked by Wall St. Rank hold SPHS as of Q3 2019.

  • A.R.T. Advisors reported no remaining Sophiris Bio, Inc. position as of Q3 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 14,704 Sophiris Bio, Inc. shares in Q3 2019, an estimated $12K.
  • A.R.T. Advisors first reported a position in Sophiris Bio, Inc. in Q3 2016 and held it in 3 quarters.
  • A.R.T. Advisors's Sophiris Bio, Inc. position peaked at $123K in Q3 2018.
  • 25 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.